- Hem
- Om universitetet
- Hitta person
- Elisabeth Odin
Elisabeth Odin
Forskningslaborant
Avd för kirurgiAnknuten till forskning
Avd för kirurgi-
Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon
Cancer
Helena Taflin, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren, Elinor Bexe-Lindskog
Cancers - 2022 -
Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with
arfolitixorin
Helena Taflin, Elisabeth Odin, Göran Carlsson, R. Tell, Bengt Gustavsson, Yvonne Wettergren
Cancer Chemotherapy and Pharmacology - 2021 -
Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal
adenocarcinoma
M. Oman, Yvonne Wettergren, Elisabeth Odin, S. Westermark, Peter Naredi, O. Hemmingsson, Helena Taflin
Cancer Chemotherapy and Pharmacology - 2021 -
Folate pathway genes linked to mitochondrial biogenesis and respiration are associated with outcome of patients with stage III colorectal
cancer
Elisabeth Odin, Arvid Sondén, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren
Tumor Biology - 2019 -
Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal
cancer
Helena Taflin, Elisabeth Odin, Kristoffer Derwinger, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren
Cancer Chemotherapy and Pharmacology - 2018 -
Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of
action
P. V. Danenberg, Bengt Gustavsson, P. Johnston, P. Lindberg, R. Moser, Elisabeth Odin, G. J. Peters, N. Petrelli
Critical Reviews in Oncology Hematology - 2016 -
Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12
supplementation.
Clemens C Stoffregen, Elisabeth Odin, Göran Carlsson, Göran Kurlberg, Hillevi Björkqvist, Maria T Tångefjord, Bengt Gustavsson
Anti-cancer drugs - 2016 -
Expression of Folate Pathway Genes in Stage III Colorectal Cancer Correlates with Recurrence Status following Adjuvant Bolus 5-FU-Based
Chemotherapy.
Elisabeth Odin, Arvid Sondén, Bengt Gustavsson, Göran Carlsson, Yvonne Wettergren
Molecular medicine (Cambridge, Mass.) - 2015 -
Phase 1 dose de-escalation trial of the endogenous folate [6R]-5,10-methylene tetrahydrofolate in combination with fixed-dose pemetrexed as neoadjuvant therapy in patients with resectable rectal
cancer.
Bengt Gustavsson, Göran Carlsson, Torbjörn Swartling, Göran Kurlberg, Kristoffer Derwinger, Hillevi Björkqvist, Elisabeth Odin, Fernando Gibson
Investigational new drugs - 2015 -
A pharmacokinetic and pharmacodynamic investigation of Modufolin(®) compared to Isovorin (®) after single dose intravenous administration to patients with colon cancer: a randomized
study.
Yvonne Wettergren, Helena Taflin, Elisabeth Odin, Karl Kodeda, Kristoffer Derwinger
Cancer chemotherapy and pharmacology - 2015 -
Folate levels measured by LC-MS/MS in patients with colorectal cancer treated with different leucovorin
dosages.
Helena Taflin, Yvonne Wettergren, Elisabeth Odin, Kristoffer Derwinger
Cancer chemotherapy and pharmacology - 2014 -
Pretherapeutic uracil and dihydrouracil levels in saliva of colorectal cancer patients are associated with toxicity during adjuvant 5-fluorouracil-based
chemotherapy.
Göran Carlsson, Elisabeth Odin, Bengt Gustavsson, Yvonne Wettergren
Cancer chemotherapy and pharmacology - 2014 -
Folate Levels and Polymorphisms in the Genes MTHFR, MTR, and TS in Colorectal
Cancer.
Helena Taflin, Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Kristoffer Derwinger
Clinical Medicine Insights. Oncology - 2014 -
Determination of reduced folates in tumor and adjacent mucosa of colorectal cancer patients using
LC-MS/MS.
Elisabeth Odin, Yvonne Wettergren, Göran Carlsson, Bengt Gustavsson
Biomedical chromatography : BMC - 2013 -
Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-flurorouracil-based
chemotherapy.
Yvonne Wettergren, Göran Carlsson, Elisabeth Odin, Bengt Gustavsson
Cancer - 2012 -
Comparison of bacterial quantities in left and right colon biopsies and
faeces.
Anna Lyra, Sofia Forssten, Peter Rolny, Yvonne Wettergren, Sampo J Lahtinen, Krista Salli, Lennart Cedgård, Elisabeth Odin, Bengt Gustavsson, Arthur C Ouwehand
World journal of gastroenterology : WJG - 2012 -
Thymidine Phosphorylase Gene Expression in Stage III Colorectal
Cancer.
Elinor Bexe-Lindskog, Yvonne Wettergren, Elisabeth Odin, Bengt Gustavsson, Kristoffer Derwinger
Clinical Medicine Insights. Oncology - 2012 -
Gene Polymorphisms MTHFRC677T and MTRA2756G as Predictive Factors in Adjuvant Chemotherapy for Stage III Colorectal
Cancer.
Helena Taflin, Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Kristoffer Derwinger
Anticancer research - 2011 -
MTHFR, MTR, and MTRR Polymorphisms in Relation to p16INK4A Hypermethylation in Mucosa of Patients with Colorectal
Cancer.
Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson
Molecular medicine - 2010 -
Comparison of folate derivate levels in mucosa and tumor tissue in the course of antifolate treatment with
pemetrexed
Bengt Gustavsson, Elisabeth Odin, Göran Kurlberg, Torbjörn Swartling, Göran Carlsson, H Björkqvist, Peter Kälebo, M Holmqvist, A Thareau Vaury, C Stoffregen
American Society of Clinical Oncology - 2010 -
Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: MRNA expression for 18 chemotherapy-related
genes
Bengt Gustavsson, Christopher Kaiser, Göran Carlsson, Yvonne Wettergren, Elisabeth Odin, Elinor Bexe-Lindskog, Clet Niyikiza, Ma Doreen
International Journal of Cancer - 2009 -
A study of the MTHFR gene polymorphism C677T in colorectal
cancer.
Kristoffer Derwinger, Yvonne Wettergren, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson
Clinical colorectal cancer - 2009 -
Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related
genes.
Bengt Gustavsson, Christopher Kaiser, Göran Carlsson, Yvonne Wettergren, Elisabeth Odin, Elinor Bexe-Lindskog, Clet Niyikiza, Doreen Ma
International journal of cancer. Journal international du cancer - 2009 -
p16(INK4a) Gene Promoter Hypermethylation in Mucosa as a Prognostic Factor for Patients with Colorectal
Cancer.
Yvonne Wettergren, Elisabeth Odin, Staffan Nilsson, Göran Carlsson, Bengt Gustavsson
Molecular medicine - 2008 -
Colorectal carcinomas with microsatellite instability display increased thymidylate synthase gene expression
levels.
Elisabeth Odin, Yvonne Wettergren, Staffan Nilsson, Göran Carlsson, Bengt Gustavsson
Clinical Colorectal Cancer - 2007 -
Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal
cancer
Elisabeth Odin, Yvonne Wettergren, Göran Carlsson, Peter Danenberg, Angelo Termini, Roger Willen, Bengt Gustavsson
Clin Colorectal Cancer - 2006 -
Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma
patients
Yvonne Wettergren, Elisabeth Odin, Staffan Nilsson, Roger Willen, Göran Carlsson, Bengt Gustavsson
Cancer Detect Prev - 2005 -
Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer
patients.
Elisabeth Odin, Yvonne Wettergren, Staffan Nilsson, Roger Willén, Göran Carlsson, C Paul Spears, Lars Larsson, Bengt Gustavsson
Clinical cancer research : an official journal of the American Association for Cancer Research - 2003 -
Rapid method for relative gene expression determination in human tissues using automated capillary gel electrophoresis and multicolor
detection
Elisabeth Odin, Yvonne Wettergren, Lars Larsson, Per-Anders Larsson, Bengt Gustavsson
J Chromatogr B Biomed Sci Appl - 1999